KTTA

Pasithea Therapeutics Corp.

Healthcare · Biotechnology

$87.29 sample

-1.36 (-1.53%) 1D

Market cap

$388.5B

Price as of

2026-10-16

Latest filing

8-K · 2026-10-01

Alerts

8

Price$87.29 -14.67% 3M daily closessample

102.3087.22

2026-07-212026-08-122026-09-032026-09-242026-10-16

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 08INSInsider sell: General Counsel
Oct 01SEC10-Q filed
Sep 22SEC8-K filed: material event
Sep 11INSInsider sell: Chief Executive Officer
Sep 07INSInsider sell: General Counsel
Sep 02INSInsider buy: EVP, Operations
Aug 26INSInsider sell: Chief Executive Officer
Aug 19INSInsider sell: General Counsel

Sign up to see the real KTTA record →

Company facts

SEC EDGAR registration

Name: Pasithea Therapeutics Corp.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +42sample, -100 to +100
Reporting currency: USD

Who is positioning in KTTA

sample

Insiders: 13 insider transactions over 90 days, net selling, $705.4M
Congress: 4 members traded over 90 days
Institutions · 13F: 23 funds hold $3.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$20.8B +11.8% y/y

Q4 2024Q3 2026

Inventory$12.1B +12.4% y/y

Q4 2024Q3 2026

Accounts receivable$9.7B +10.2% y/y

Q4 2024Q3 2026

Total debt$25.3B +18.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $215.9B +5.7% 3M
Sample peer B: $92.9B -5.8% 3M
Sample peer C: $190.5B +1.7% 3M
Sample peer D: $240.4B -0.7% 3M
Sample peer E: $149.7B +4.1% 3M